SCHEMBL73956

SCHEMBL73956

c1cc(Nc2cnn[nH]2)cc(-c2cnc3ccccn23)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 2/20 0.48
CDK1 P06493 1/20 0.48
CDK4 P11802 1/20 0.48
MIF P14174 1/20 0.47
IRAK4 Q9NWZ3 2/20 0.46
FLT3 P36888 2/20 0.44
PKM P14618 3/20 0.43
KDR P35968 6/20 0.43
FGFR3 P22607 5/20 0.43
IKBKE Q14164 1/20 0.42
TBK1 Q9UHD2 1/20 0.42
PRMT5 O14744 1/20 0.41
WDR77 Q9BQA1 1/20 0.41
PIK3CA P42336 2/20 0.41
NPC1 O15118 1/20 0.39
GAA P10253 1/20 0.39
HPGD P15428 1/20 0.39
HTT P42858 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3587763 0.86 KDR (0.60) CDK2FLT3KDRFGFR3PRMT5
SCHEMBL13407687 0.85 GABRG2 (0.53) FLT3KDRFGFR3PRMT5WDR77
SCHEMBL72363 0.82 IRAK4 (0.61) CDK2CDK1CDK4MIFIRAK4
SCHEMBL72956 0.79 CDK2 (0.60) CDK2CDK1CDK4MIFIRAK4
SCHEMBL74774 0.77 CDK2 (0.53) CDK2CDK1CDK4MIFIRAK4
SCHEMBL73262 0.76 FGFR3 (0.53) CDK2CDK1CDK4MIFIRAK4
SCHEMBL13407688 0.75 KDR (0.54) FLT3KDRFGFR3
SCHEMBL71795 0.75 IRAK4 (0.53) CDK2CDK1CDK4MIFIRAK4
SCHEMBL73153 0.74 CDK2 (0.58) CDK2CDK1CDK4MIFIRAK4
SCHEMBL73961 0.74 IRAK4 (0.52) CDK2CDK1CDK4MIFIRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8131527-B1 FGFR pharmacophore compounds ASTEX THERAPEUTICS LTD. (GB) 2012-03-06 US disclosed
US-8131527-B1 FGFR pharmacophore compounds ASTEX THERAPEUTICS LTD. (GB) 2012-03-06 US disclosed